News
Pfizer, Ursula von der Leyen
Digest more
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...
But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...
1d
MedPage Today on MSNPfizer Confirms: Leading JAK Inhibitor Often Comes With Weight GainPatients taking tofacitinib (Xeljanz) in the drug's late-stage and post-marketing studies were more likely than those on ...
Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands ...
Pfizer's 7.45% dividend yield can't offset weak growth, declining EPS, and patent risks. Read more on PFE and why analysts ...
Explore more
After an EU court ruled that Ursula von der Leyen should have published text messages she exchanged with the CEO of Pfizer, MEPs across all party lines have welcomed the decision as a victory against ...
4d
24/7 Wall St. on MSNPfizer (NYSE:PFE) Hasn't Been This Cheap in 13 Years. Time to Buy?Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results